Finding and assessing treatment effect sweet spots in clinical trial data

TL;DR

This paper introduces a method to identify the optimal range of illness severity where treatment benefits are maximized in clinical trial data, aiding personalized medicine and future trial design.

Contribution

The paper presents a novel approach that exploits the relationship between illness severity and treatment effect to find and assess treatment effect 'sweet spots' in trial data.

Findings

Identifies the 'sweet spot' of maximum treatment benefit.

Provides bias-corrected estimates of treatment effects.

Offers a p-value for statistical significance of the sweet spot.

Abstract

Identifying heterogeneous treatment effects (HTEs) in randomized controlled trials is an important step toward understanding and acting on trial results. However, HTEs are often small and difficult to identify, and HTE modeling methods which are very general can suffer from low power. We present a method that exploits any existing relationship between illness severity and treatment effect, and identifies the "sweet spot", the contiguous range of illness severity where the estimated treatment benefit is maximized. We further compute a bias-corrected estimate of the conditional average treatment effect (CATE) in the sweet spot, and a $p$-value. Because we identify a single sweet spot and $p$-value, we believe our method to be straightforward to interpret and actionable: results from our method can inform future clinical trials and help clinicians make personalized treatment recommendations.